CIFoundry

AI tools for diabetes

AI tools for diabetes care, such as insulin dosing support, glucose data analysis, remote monitoring and care management programs.

What the public record shows (updated November 2026): CIFoundry lists 13 tools whose own listing mentions diabetes. Of these, 1 names health-system users, 1 links to a published study and 10 list FDA authorization.

Listed A–Z. We don’t rank tools or recommend vendors, and no one can pay to appear.

All 13 tools

Listed A–Z. Listing is free, and no one can pay to change the order.

Nephrology
FDA Cleared

KidneyIntelX.dkd (Renalytix)

Renalytix

KidneyIntelX.dkd is an FDA-authorized, AI-enabled prognostic test that assesses the risk of progressive kidney-function decline in adults with type 2 diabetes and early-stage chronic kidney disease. A machine-learning algorithm (a random-forest model) combines blood-based biomarkers, inherited genetics, and EHR data to stratify patients into low, moderate, or high risk over a five-year horizon, helping clinicians target early treatment. Developed at the Icahn School of Medicine at Mount Sinai and licensed to Renalytix, it received FDA De Novo marketing authorization in June 2023, establishing a new device category for chronic kidney disease progression prognostics.

  • FDAon record
  • Epicnot on record
  • Named usersnot on record
  • Studynot on record
nephrologykidney diseasediabetic kidney disease+3
Endocrinology

Twin Health

Twin Health

Twin Health is a metabolic care program built on an AI "digital twin", a model of each member's metabolism created from a continuous glucose monitor, blood pressure cuff, smart scale and activity tracker. The AI turns this data into daily guidance on food, sleep, activity and stress, and a clinical care team of providers and coaches uses it to reduce or stop medications where safe. It targets type 2 diabetes, prediabetes and obesity. In a Cleveland Clinic randomized trial published in NEJM Catalyst (2025, 150 patients), 71% of participants reached an A1C below 6.5% without glucose-lowering drugs other than metformin, versus 2.4% with usual care. It is sold mainly to employers and health plans with outcome-based pricing.

  • FDAnot on record
  • Epicnot on record
  • Named usersnot on record
  • Studyon record
Digital twinType 2 diabetesCGM+2

Questions to ask about diabetes tools

  • Is it for type 1, type 2, gestational diabetes, or all of them?
  • Which glucose meters, CGMs or pumps does it work with?
  • Who acts on its suggestions: the patient, a nurse, or the physician?

For the full checklist, see the evaluation guides.

How tools are matched

A tool appears here when its own listing (name, description or tags) mentions one of these terms: diabetes, insulin, glucose monitoring. A tool that helps with diabetes but doesn’t say so in its listing won’t appear yet. Spot a tool that’s missing or doesn’t belong? Use “Request a correction” on the tool page, or email [email protected], or see how we list tools.

Get weekly updates for Endocrinology

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Other conditions